MATTHEW HESELTON

MT MORRIS, PA

This page merges CMS profile IDs: 11344885, 7229887 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$644.54

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $326.53 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $326.5319

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $65.644
GlaxoSmithKline, LLC. $57.673
DEXCOM, INC. $53.923
Lilly USA, LLC $51.383
Exact Sciences Corporation $36.522
Acerta Pharma LLC $29.452
Organon LLC $16.311
Amgen Inc. $15.641

By program year

Program yearAmountRecords
2019 $19.161
2020 $16.581
2022 $42.712
2023 $239.5614
2024 $326.5319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096612744 Novo Nordisk Inc $17.05 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096658151 Novo Nordisk Inc $13.53 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096725481 Novo Nordisk Inc $13.95 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097827322 Novo Nordisk Inc $21.11 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104682705 AstraZeneca Pharmaceuticals LP $15.74 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105388595 AstraZeneca Pharmaceuticals LP $13.71 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114414482 Exact Sciences Corporation $15.83 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114414486 Exact Sciences Corporation $20.69 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116116892 GlaxoSmithKline, LLC. $17.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116126037 GlaxoSmithKline, LLC. $17.72 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116593290 GlaxoSmithKline, LLC. $22.95 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117276762 Amgen Inc. $15.64 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135170290 Lilly USA, LLC $15.85 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135183531 Lilly USA, LLC $17.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135197472 Lilly USA, LLC $17.78 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136278388 Organon Llc $16.31 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153321010 Dexcom, Inc. $22.02 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153321012 Dexcom, Inc. $13.25 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153321014 Dexcom, Inc. $18.65 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 11344885, 7229887

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.